CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
017 works in treating patients with non-Hodgkin's lymphoma whose disease has come back or has not responded to treatment....
Phase 1
Birmingham, Alabama, United States and 13 other locations
dose of BGB-11417 monotherapy for relapsed or refractory mantle cell lymphoma. Part 2 evaluates efficacy of BGB-11417 monotherapy at the rec...
Phase 1, Phase 2
Birmingham, Alabama, United States and 104 other locations
A Phase 2 study to evaluate the efficacy of nanatinostat in combination with valganciclovir in patients with relapsed/refractory EBV-positive lymphomas...
Phase 2
Birmingham, Alabama, United States and 93 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Birmingham, Alabama, United States and 215 other locations
in participants diagnosed with relapsed or refractory marginal zone lymphoma (MZL) who are naive to or were previously treated with a Bruton...
Phase 2
Birmingham, Alabama, United States and 85 other locations
T cells, in subjects with relapsed or refractory B-cell non-Hodgkin lymphoma.The study will consist of 2 parts: dose-escalation (Part A) and...
Phase 1
Birmingham, Alabama, United States and 13 other locations
pharmacokinetics, pharmacodynamics, and anti-tumor activity of DR-01 in adult patients with large granular lymphocytic leukemia or cytotoxic lymphomas...
Phase 1, Phase 2
Birmingham, Alabama, United States and 19 other locations
regimens in participants with relapsed or refractory mantle cell lymphoma (MCL) previously treated either with or without a Bruton's tyrosin...
Phase 2
Birmingham, Alabama, United States and 102 other locations
of CB-010 in adults with relapsed/refractory B cell non-Hodgkin lymphoma after lymphodepletion consisting of cyclophosphamide and fludarabin...
Phase 1
Birmingham, Alabama, United States and 29 other locations
trial will enroll patients with relapsed/refractory non-Hodgkin lymphoma of B-cell origin and is conducted in two phases. The primary object...
Phase 1, Phase 2
Birmingham, Alabama, United States and 20 other locations
Clinical trials
Research sites
Resources
Legal